Avino Silver & Gold Mines Ltd. press release
Biomira Inc. Announces U.S. $100 Million Shelf Registration
TSX - Toronto Stock Exchange · Silver · Gold · Copper · Canada
EDMONTON, Sept. 27 /CNW/ - Biomira Inc. (Nasdaq: BIOM) (TSX: BRA) today announced that it has received final clearance from the applicable Canadian regulatory authorities with respect to a U.S. $100 million shelf prospectus filed in specified Canadian jurisdictions. Biomira concurrently filed a shelf registration statement in the United States on Form F-10, which was effective upon filing in definitive form. The shelf registration became effective in both countries on September 26, 2006. "Biomira is approaching an important transition as we look to acquire or in-license additional cancer therapeutics to expand our pipeline," commented Dr. Robert Kirkman, President and CEO. "This shelf registration will provide us with the flexibility to obtain financing efficiently, as market conditions allow, to support both internal development and future partnering activities." The shelf prospectus will be effective for approximately 25 months. The terms of any offering under the shelf prospectus will be established at the time of the offering and will be described in a prospectus supplement filed at that time.
About Biomira Biomira is a biotechnology company specializing in the development of innovative therapeutic approaches to cancer management. Biomira's commitment to the treatment of cancer currently focuses on the development of synthetic vaccines and novel strategies for cancer immunotherapy.
>